01/03/2015 01:56:17 Free Membership Login

Inovio Pharmaceuticals, Inc. News (NASDAQ:INO)

DateTimeSource
Headline
02/03/201510:15AMBWU.S. Congressman Patrick Meehan to Present Keynote Address at 22nd Annual Groundhog Investment Forum
Congressman Meehan chaired the House Subcommittee on Cybersecurity in the 113th Congress and serves on the House Ways and Means Committee Emerald Asset Management, Inc. has announced that U.S. Congressman Patrick Meehan will present the keynote address to the close the 22nd annual Groundhog Day Investment Forum on Thursday... More...>>
02/02/20158:00AMGLOBEInovio Pharmaceuticals to Present at Upcoming Investor Conferences
PLYMOUTH MEETING, Pa., Feb. 2, 2015 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (Nasdaq:INO) announced today that President and CEO, Dr. J. Joseph Kim, will present a corporate overview at the 22nd Annual Emerald Groundhog Day Investment Forum on Thursday, February 5th at 2:45 PM ET. Hosted by Emerald Asset Management... More...>>
01/29/201512:05PMBWInvestment Industry to Gather in Philadelphia at 22nd Annual Groundhog Day Investment Forum
The Emerald Groundhog Day Investment Forum marks its 22nd annual event on February 5th in Philadelphia, PA with over 20 companies scheduled to present. Emerald Asset Management, Inc. will welcome hundreds of investment industry professionals to the 22nd annual Emerald Groundhog Day Investment Forum, scheduled to be held... More...>>
01/29/20158:00AMPRNUSInovio Pharmaceuticals Appoints Dr. Mark Gelder to Lead Clinical Development of Cervical Dysplasia and Cancer Programs
Inovio Pharmaceuticals Appoints Dr. Mark Gelder to Lead Clinical Development of Cervical Dysplasia and Cancer Programs Dr. Gelder's Accomplishments Include Successful Development of Cancer Therapies at Pfizer, Wyeth and Bayer PR Newswire PLYMOUTH MEETING, Pa., Jan. 29, 2015 PLYMOUTH MEETING, Pa., Jan. 29, 2015 /PRNewswire/... More...>>
01/14/20159:00AMIHNWThe Future of Cancer Science
Scientists at Propanc Health Group Corporation Pioneer New Treatment in the Fight against Metastatic Cancer   When a patient is first struck down with cancer, the first question asked is whether it has spread to other parts of the body.  Sadly, if confirmed the cancer has spread, or metastasized, it often means... More...>>
01/07/20158:00AMPRNUSInovio Pharmaceuticals' CEO to Present at 2015 Biotech Showcase Conference
Inovio Pharmaceuticals' CEO to Present at 2015 Biotech Showcase Conference PR Newswire PLYMOUTH MEETING, Pa., Jan. 7, 2015 PLYMOUTH MEETING, Pa., Jan. 7, 2015 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced that President and CEO, Dr. J. Joseph Kim, will present a company overview at the 2015 Biotech... More...>>
01/06/20158:00AMPRNUSInovio Pharmaceuticals HIV Immunotherapy Shows Characteristics Considered Vital to Treating HIV
Inovio Pharmaceuticals HIV Immunotherapy Shows Characteristics Considered Vital to Treating HIV Phase I Trial Reveals DNA Immunotherapy Results Were Similar To HIV-Infected Patients Whose Disease Did Not Progress PR Newswire PLYMOUTH MEETING, Pa., Jan. 6, 2015 PLYMOUTH MEETING, Pa., Jan. 6, 2015 /PRNewswire/ -- Inovio... More...>>
12/18/20146:00AMPRNUSInovio Pharmaceuticals Initiates DNA Immunotherapy Trial for Breast, Lung and Pancreatic Cancers
Inovio Pharmaceuticals Initiates DNA Immunotherapy Trial for Breast, Lung and Pancreatic Cancers Active Immunotherapy Targets hTERT Gene Associated with 85% of Cancers Preclinical Studies Showed Tumor Shrinkage and Prevention of Tumor Recurrence PR Newswire PLYMOUTH MEETING, Pa., Dec. 18, 2014 PLYMOUTH MEETING, Pa., Dec... More...>>
12/17/20148:00AMPRNUSInovio Pharmaceuticals Appoints Zane Yang, M.D. Vice President, Clinical Development, Oncology
Inovio Pharmaceuticals Appoints Zane Yang, M.D. Vice President, Clinical Development, Oncology Dr. Yang led Janssen's prostate cancer and solid tumor therapeutic area in the U.S. PR Newswire PLYMOUTH MEETING, Pa., Dec. 17, 2014 PLYMOUTH MEETING, Pa., Dec. 17, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO... More...>>
12/15/20148:00AMPRNUSInovio Pharmaceuticals Added to NASDAQ Biotechnology Index
Inovio Pharmaceuticals Added to NASDAQ Biotechnology Index PR Newswire PLYMOUTH MEETING, Pa., Dec. 15, 2014 PLYMOUTH MEETING, Pa., Dec. 15, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today it has been added to the NASDAQ Biotechnology Index (NBI). The addition to the NASDAQ Biotechnology... More...>>
11/24/20146:00AMPRNUSInovio Pharmaceuticals to Ring Opening Bell Nov 25th on the Nasdaq Stock Market
Inovio Pharmaceuticals to Ring Opening Bell Nov 25th on the Nasdaq Stock Market PR Newswire PLYMOUTH MEETING, Pa., Nov. 24, 2014 PLYMOUTH MEETING, Pa., Nov. 24, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today that Dr. J. Joseph Kim, President and CEO of Inovio Pharmaceuticals, will be joined... More...>>
11/20/20148:00AMPRNUSInovio Pharmaceuticals Melanoma DNA Immunotherapy Inhibits Tumor Growth and Increases Survival in Preclinical Study
Inovio Pharmaceuticals Melanoma DNA Immunotherapy Inhibits Tumor Growth and Increases Survival in Preclinical Study Another Active Immunotherapy Product Added to Inovio's Growing Cancer R&D Pipeline PR Newswire PLYMOUTH MEETING, Pa., Nov. 20, 2014 PLYMOUTH MEETING, Pa., Nov. 20, 2014 /PRNewswire/ -- Inovio Pharmaceuticals... More...>>
11/17/20143:00AMPRNUSInovio Pharmaceuticals to Independently Develop Prostate Cancer Immunotherapy; Will Maintain Collaboration and License Agreem...
Inovio Pharmaceuticals to Independently Develop Prostate Cancer Immunotherapy; Will Maintain Collaboration and License Agreement with Roche for Inovio's Hepatitis B Immunotherapy PR Newswire PLYMOUTH MEETING, Pa., Nov. 17, 2014 PLYMOUTH MEETING, Pa., Nov. 17, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ:... More...>>
11/11/20146:00AMPRNUSInovio to Present at Upcoming Investor Conferences
Inovio to Present at Upcoming Investor Conferences PR Newswire PLYMOUTH MEETING, Pa., Nov. 11, 2014 PLYMOUTH MEETING, Pa., Nov. 11, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today that Dr. J. Joseph Kim, President & CEO, will present a corporate overview at the upcoming Stifel Healthcare... More...>>
11/10/20146:00AMPRNUSInovio Pharmaceuticals Reports 2014 Third Quarter Financial Results
Inovio Pharmaceuticals Reports 2014 Third Quarter Financial Results PR Newswire PLYMOUTH MEETING, Pa., Nov. 10, 2014 PLYMOUTH MEETING, Pa., Nov. 10, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) today reported financial results for the quarter ended September 30, 2014. Total revenue was $1.8 million and... More...>>
11/04/20146:00AMPRNUSInovio Pharmaceuticals to Report Third Quarter 2014 Financial Results on November 10, 2014
Inovio Pharmaceuticals to Report Third Quarter 2014 Financial Results on November 10, 2014 PR Newswire PLYMOUTH MEETING, Pa., Nov. 4, 2014 PLYMOUTH MEETING, Pa., Nov. 4, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today that it will host a conference call and live webcast to report its third... More...>>
10/21/20146:00AMPRNUSInovio Pharmaceuticals, MedImmune and the University of Pennsylvania Partner to Combat Influenza and Antibiotic Resistant Bac...
Inovio Pharmaceuticals, MedImmune and the University of Pennsylvania Partner to Combat Influenza and Antibiotic Resistant Bacteria PR Newswire PLYMOUTH MEETING, Pa., Oct. 21, 2014 PLYMOUTH MEETING, Pa., Oct. 21, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today the Defense Advanced Research... More...>>
09/30/20147:00AMPRNUSInovio Pharmaceuticals Appoints Vice President of Commercial Development
Inovio Pharmaceuticals Appoints Vice President of Commercial Development New Executive Brings Experience from Merck, Boehringer Ingelheim, and Proctor & Gamble PR Newswire PLYMOUTH MEETING, Pa., Sept. 30, 2014 PLYMOUTH MEETING, Pa., Sept. 30, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) today announced... More...>>
09/24/201410:41AMDJNCorrection to Inovio, GeneOne Headline
"Inovia, GeneOne to Advance Ebola Vaccine to Human Trials," at 8:41 a.m. EDT, misstated the name of company in the headline. The company is Inovio, not Inovia. Subscribe to WSJ: http://online.wsj.com?mod=djnwires More...>>
09/24/20149:50AMDJNU.S. Hot Stocks: Hot Stocks to Watch
Among the companies with shares expected to actively trade in Wednesday's session are Citizens Financial Group Inc. (CFG), Newell Rubbermaid Inc. (NWL) and Acorda Therapeutics Inc. (ACOR). Citizens Financial, a U.S. unit of Royal Bank of Scotland Group PLC (RBS, RBS.LN), is expected to begin trading on Wednesday after... More...>>


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us amex ino150301 01:56